Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 287

1.

Constitutively Higher Level of GSTT2 in Esophageal Tissues From African Americans Protects Cells Against DNA Damage.

Ferrer-Torres D, Nancarrow DJ, Steinberg H, Wang Z, Kuick R, Weh KM, Mills RE, Ray D, Ray P, Lin J, Chang AC, Reddy RM, Orringer MB, Canto MI, Shaheen NJ, Kresty LA, Chak A, Wang TD, Rubenstein JH, Beer DG.

Gastroenterology. 2019 Apr;156(5):1404-1415. doi: 10.1053/j.gastro.2018.12.004. Epub 2018 Dec 19.

PMID:
30578782
2.

Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake Correlates with KRAS and EMT Gene Signatures in Operable Esophageal Adenocarcinoma.

Heiden BT, Patel N, Nancarrow DJ, Hermann M, Brown RKJ, Orringer MB, Lin J, Chang AC, Carrott PW, Lynch WR, Zhao L, Beer DG, Reddy RM.

J Surg Res. 2018 Dec;232:621-628. doi: 10.1016/j.jss.2018.06.046. Epub 2018 Aug 10.

PMID:
30463782
3.

Gordon F. Murray, MD, January 8, 1939 to May 21, 2018.

Orringer MB.

Ann Thorac Surg. 2018 Oct;106(4):1267-1270. doi: 10.1016/j.athoracsur.2018.07.005. Epub 2018 Aug 3.

PMID:
30081027
4.

18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer.

Heiden BT, Chen G, Hermann M, Brown RKJ, Orringer MB, Lin J, Chang AC, Carrott PW, Lynch WR, Zhao L, Beer DG, Reddy RM.

PLoS One. 2018 Jul 2;13(7):e0199970. doi: 10.1371/journal.pone.0199970. eCollection 2018.

5.

Silencing of Long Noncoding RNA MIR22HG Triggers Cell Survival/Death Signaling via Oncogenes YBX1, MET, and p21 in Lung Cancer.

Su W, Feng S, Chen X, Yang X, Mao R, Guo C, Wang Z, Thomas DG, Lin J, Reddy RM, Orringer MB, Chang AC, Yang Z, Beer DG, Chen G.

Cancer Res. 2018 Jun 15;78(12):3207-3219. doi: 10.1158/0008-5472.CAN-18-0222. Epub 2018 Apr 18.

6.

Increased Variance in Oral and Gastric Microbiome Correlates With Esophagectomy Anastomotic Leak.

Reddy RM, Weir WB, Barnett S, Heiden BT, Orringer MB, Lin J, Chang AC, Carrott PW, Lynch WR, Beer DG, Fenno JC, Kapila Y.

Ann Thorac Surg. 2018 Mar;105(3):865-870. doi: 10.1016/j.athoracsur.2017.08.061. Epub 2018 Jan 5.

PMID:
29307454
7.

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes.

Samuels SE, Stenmark MH, Lee JY, McHugh JB, Hayman JA, Orringer MB, Urba SG, Sun L, Xie C, Kong FM, Cuneo KC.

Adv Radiat Oncol. 2017 May 25;2(3):308-315. doi: 10.1016/j.adro.2017.05.003. eCollection 2017 Jul-Sep.

8.

Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers.

Murlidhar V, Reddy RM, Fouladdel S, Zhao L, Ishikawa MK, Grabauskiene S, Zhang Z, Lin J, Chang AC, Carrott P, Lynch WR, Orringer MB, Kumar-Sinha C, Palanisamy N, Beer DG, Wicha MS, Ramnath N, Azizi E, Nagrath S.

Cancer Res. 2017 Sep 15;77(18):5194-5206. doi: 10.1158/0008-5472.CAN-16-2072. Epub 2017 Jul 17.

9.

Evaluation of acute and chronic pain outcomes after robotic, video-assisted thoracoscopic surgery, or open anatomic pulmonary resection.

Kwon ST, Zhao L, Reddy RM, Chang AC, Orringer MB, Brummett CM, Lin J.

J Thorac Cardiovasc Surg. 2017 Aug;154(2):652-659.e1. doi: 10.1016/j.jtcvs.2017.02.008. Epub 2017 Feb 14.

PMID:
28291605
10.

The University of Michigan Cardiac and Thoracic Surgery Program.

Prager RL, Bove EL, Chang AC, Orringer MB.

Semin Thorac Cardiovasc Surg. 2016 Autumn;28(3):705-711. doi: 10.1053/j.semtcvs.2016.08.017. Epub 2016 Sep 28.

PMID:
28285677
11.

Transhiatal Esophagectomy: How I Teach It.

Orringer MB.

Ann Thorac Surg. 2016 Nov;102(5):1432-1437. doi: 10.1016/j.athoracsur.2016.09.044. No abstract available.

PMID:
27772570
12.

Worldwide Esophageal Cancer Collaboration: clinical staging data.

Rice TW, Apperson-Hansen C, DiPaola LM, Semple ME, Lerut TE, Orringer MB, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, Wijnhoven BP, Chen KN, Davies AR, D'Journo XB, Kesler KA, Luketich JD, Ferguson MK, Räsänen JV, van Hillegersberg R, Fang W, Durand L, Allum WH, Cecconello I, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Ishwaran H, Blackstone EH.

Dis Esophagus. 2016 Oct;29(7):707-714. doi: 10.1111/dote.12493.

13.

Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data.

Rice TW, Lerut TE, Orringer MB, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, van Lanschot J, Chen KN, Davies AR, D'Journo XB, Kesler KA, Luketich JD, Ferguson MK, Räsänen JV, van Hillegersberg R, Fang W, Durand L, Allum WH, Cecconello I, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Ishwaran H, Apperson-Hansen C, DiPaola LM, Semple ME, Blackstone EH.

Dis Esophagus. 2016 Oct;29(7):715-723. doi: 10.1111/dote.12513.

14.

Worldwide Esophageal Cancer Collaboration: pathologic staging data.

Rice TW, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, Wijnhoven BP, Chen KL, Davies AR, D'Journo XB, Kesler KA, Luketich JD, Ferguson MK, Räsänen JV, van Hillegersberg R, Fang W, Durand L, Cecconello I, Allum WH, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Lerut TE, Orringer MB, Ishwaran H, Apperson-Hansen C, DiPaola LM, Semple ME, Blackstone EH.

Dis Esophagus. 2016 Oct;29(7):724-733. doi: 10.1111/dote.12520.

15.

Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.

Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Korn WM, Leong S, Linn C, Lockhart AC, Ly QP, Mulcahy MF, Orringer MB, Perry KA, Poultsides GA, Scott WJ, Strong VE, Washington MK, Weksler B, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H.

J Natl Compr Canc Netw. 2016 Oct;14(10):1286-1312.

PMID:
27697982
16.

Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas.

Ferrer-Torres D, Nancarrow DJ, Kuick R, Thomas DG, Nadal E, Lin J, Chang AC, Reddy RM, Orringer MB, Taylor JM, Wang TD, Beer DG.

Oncotarget. 2016 Aug 23;7(34):54867-54882. doi: 10.18632/oncotarget.10253.

17.

Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer.

Reddy RM, Murlidhar V, Zhao L, Grabauskiene S, Zhang Z, Ramnath N, Lin J, Chang AC, Carrott P, Lynch W, Orringer MB, Beer DG, Nagrath S.

J Thorac Cardiovasc Surg. 2016 Mar;151(3):852-858. doi: 10.1016/j.jtcvs.2015.09.126. Epub 2015 Oct 22.

18.

IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma.

Myers AL, Lin L, Nancarrow DJ, Wang Z, Ferrer-Torres D, Thomas DG, Orringer MB, Lin J, Reddy RM, Beer DG, Chang AC.

Oncotarget. 2015 Sep 22;6(28):25897-916. doi: 10.18632/oncotarget.4532.

19.

Emergent Esophagectomy for Esophageal Perforations: A Safe Option.

Seo YD, Lin J, Chang AC, Orringer MB, Lynch WR, Reddy RM.

Ann Thorac Surg. 2015 Sep;100(3):905-9. doi: 10.1016/j.athoracsur.2015.04.055. Epub 2015 Jul 16.

PMID:
26188974
20.

MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancer.

He Y, Wang L, Liu W, Zhong J, Bai S, Wang Z, Thomas DG, Lin J, Reddy RM, Ramnath N, Carrott PW, Lynch WR, Orringer MB, Chang AC, Beer DG, Chen G.

Sci Rep. 2015 Jun 19;5:11471. doi: 10.1038/srep11471.

21.

Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma.

Lin J, Myers AL, Wang Z, Nancarrow DJ, Ferrer-Torres D, Handlogten A, Leverenz K, Bao J, Thomas DG, Wang TD, Orringer MB, Reddy RM, Chang AC, Beer DG, Lin L.

Oncotarget. 2015 Sep 8;6(26):22239-57.

22.

50TH Anniversary Landmark Commentary on Sloan H. The Breeding and Feeding of Thoracic Surgeons. Ann Thorac Surg 1975;20:371-86.

Orringer MB.

Ann Thorac Surg. 2015 Jun;99(6):1877-8. doi: 10.1016/j.athoracsur.2015.04.069. No abstract available.

PMID:
26046854
23.

Esophageal and esophagogastric junction cancers, version 1.2015.

Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Besh S, Chao J, Das P, Denlinger C, Fanta P, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Jasperson K, Keswani RN, Kleinberg LR, Korn WM, Leong S, Lockhart AC, Mulcahy MF, Orringer MB, Posey JA, Poultsides GA, Sasson AR, Scott WJ, Strong VE, Varghese TK Jr, Washington MK, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H; National comprehensive cancer network.

J Natl Compr Canc Netw. 2015 Feb;13(2):194-227.

PMID:
25691612
24.

A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma.

Nadal E, Zhong J, Lin J, Reddy RM, Ramnath N, Orringer MB, Chang AC, Beer DG, Chen G.

Clin Cancer Res. 2014 Jun 15;20(12):3107-17. doi: 10.1158/1078-0432.CCR-13-3348. Epub 2014 May 15.

25.

Herbert Sloan, MD, October 10, 1914 - May 17, 2013.

Orringer MB.

Ann Thorac Surg. 2014 Mar;97(3):1116-9. doi: 10.1016/j.athoracsur.2013.11.065.

PMID:
24580939
26.

Preoperative pulmonary artery pressure and mortality after lung transplantation.

Ohtsuka T, Flaherty KR, Lin J, Lama VN, Reddy RM, Orringer MB, Chan KM, Chang AC.

Asian Cardiovasc Thorac Ann. 2013 Jun;21(3):326-30. doi: 10.1177/0218492312459972.

PMID:
24570500
27.

Education above and beyond: innovative STS educational initiatives.

Levitsky S, Chitwood WR, Orringer MB, Mack MJ.

Ann Thorac Surg. 2014 Jan;97(1 Suppl):S29-33. doi: 10.1016/j.athoracsur.2013.10.006. No abstract available.

PMID:
24384246
28.

Imaging in thoracic oncology: case studies from Multidisciplinary Thoracic Tumor Board (part 1 of 2 part series).

Quint LE, Reddy RM, Lin J, Arenberg DA, Speers C, Hayman JA, Kong FP, Orringer MB, Kalemkerian GP.

Cancer Imaging. 2013 Dec 6;13(3):429-39. doi: 10.1102/1470-7330.2013.0037.

29.

Imaging in thoracic oncology: case studies from Multidisciplinary Thoracic Tumor Board: (part 2 of 2 part series).

Quint LE, Reddy RM, Lin J, Arenberg DA, Speers C, Hayman JA, Kong FP, Orringer MB, Kalemkerian GP.

Cancer Imaging. 2013 Dec 6;13(3):440-7. doi: 10.1102/1470-7330.2013.0030.

30.

Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies.

Bergeron EJ, Lin J, Chang AC, Orringer MB, Reddy RM.

J Thorac Cardiovasc Surg. 2014 Feb;147(2):765-71: Discussion 771-3. doi: 10.1016/j.jtcvs.2013.10.003. Epub 2013 Dec 4.

31.

Factors associated with rapid progression to esophagectomy for benign disease.

Madenci AL, Reames BN, Chang AC, Lin J, Orringer MB, Reddy RM.

J Am Coll Surg. 2013 Nov;217(5):889-95. doi: 10.1016/j.jamcollsurg.2013.07.384. Epub 2013 Sep 11.

PMID:
24035659
32.

Inaugural discussions in cardiothoracic treatment and care: surgery for esophageal cancer, November 16, 2012, Boston, MA.

Darling GE, Altorki NK, Luketich JD, Orringer MB.

Semin Thorac Cardiovasc Surg. 2013 Spring;25(1):38-55. doi: 10.1053/j.semtcvs.2013.04.001. No abstract available.

PMID:
23800528
33.

Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.

Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Meredith K, Mulcahy MF, Orringer MB, Posey JA, Sasson AR, Scott WJ, Strong VE, Varghese TK Jr, Warren G, Washington MK, Willett C, Wright CD, McMillian NR, Sundar H; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 May 1;11(5):531-46.

PMID:
23667204
34.

Decreased core muscle size is associated with worse patient survival following esophagectomy for cancer.

Sheetz KH, Zhao L, Holcombe SA, Wang SC, Reddy RM, Lin J, Orringer MB, Chang AC.

Dis Esophagus. 2013 Sep-Oct;26(7):716-22. doi: 10.1111/dote.12020. Epub 2013 Jan 25.

35.

Thromboembolic events before esophagectomy for esophageal cancer do not result in worse outcomes.

Teman NR, Silski L, Zhao L, Kober M, Urba SC, Orringer MB, Chang AC, Lin J, Reddy RM.

Ann Thorac Surg. 2012 Oct;94(4):1118-24; discussion 1124-5. doi: 10.1016/j.athoracsur.2012.05.109. Epub 2012 Aug 2.

PMID:
22858275
36.

Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer.

Schneider BJ, Lee JS, Hayman JA, Chang AC, Orringer MB, Pickens A, Pan CC, Merajver SD, Urba SG.

Invest New Drugs. 2013 Apr;31(2):435-42. doi: 10.1007/s10637-012-9864-0. Epub 2012 Jul 31.

37.

Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinoma.

Lin L, Bass AJ, Lockwood WW, Wang Z, Silvers AL, Thomas DG, Chang AC, Lin J, Orringer MB, Li W, Glover TW, Giordano TJ, Lam WL, Meyerson M, Beer DG.

Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4251-6. doi: 10.1073/pnas.1011989109. Epub 2012 Feb 28.

38.

Esophageal and esophagogastric junction cancers.

Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Varghese TK Jr, Warren G, Washington MK, Willett C, Wright CD; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2011 Aug 1;9(8):830-87. No abstract available.

PMID:
21900218
39.

Development and validation of a quantitative real-time polymerase chain reaction classifier for lung cancer prognosis.

Chen G, Kim S, Taylor JM, Wang Z, Lee O, Ramnath N, Reddy RM, Lin J, Chang AC, Orringer MB, Beer DG.

J Thorac Oncol. 2011 Sep;6(9):1481-7. doi: 10.1097/JTO.0b013e31822918bd.

40.

Defining a "successful" esophagectomy.

Orringer MB.

Ann Surg. 2011 Jan;253(1):6-7. doi: 10.1097/SLA.0b013e3182057169. No abstract available.

PMID:
21233604
41.

Refractory cervical esophagogastric anastomotic strictures: management and outcomes.

Davis SJ, Zhao L, Chang AC, Orringer MB.

J Thorac Cardiovasc Surg. 2011 Feb;141(2):444-8. doi: 10.1016/j.jtcvs.2010.10.011. Epub 2010 Dec 15.

42.

Gastric cancer.

Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, Denlinger C, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Meredith K, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Washington MK, Willett C, Wood DE, Wright CD, Yang G; NCCN Gastric Cancer Panel.

J Natl Compr Canc Netw. 2010 Apr;8(4):378-409. No abstract available.

PMID:
20410333
43.

Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma.

Hartojo W, Silvers AL, Thomas DG, Seder CW, Lin L, Rao H, Wang Z, Greenson JK, Giordano TJ, Orringer MB, Rehemtulla A, Bhojani MS, Beer DG, Chang AC.

Transl Oncol. 2010 Apr;3(2):99-108.

44.

Outcomes after esophagectomy in patients with prior antireflux or hiatal hernia surgery.

Chang AC, Lee JS, Sawicki KT, Pickens A, Orringer MB.

Ann Thorac Surg. 2010 Apr;89(4):1015-21; discussion 1022-3. doi: 10.1016/j.athoracsur.2009.10.052.

45.

Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity.

Silvers AL, Lin L, Bass AJ, Chen G, Wang Z, Thomas DG, Lin J, Giordano TJ, Orringer MB, Beer DG, Chang AC.

Clin Cancer Res. 2010 Apr 1;16(7):2009-21. doi: 10.1158/1078-0432.CCR-09-2801. Epub 2010 Mar 23. Erratum in: Clin Cancer Res. 2012 Jun 15;18(12):3490.

46.

Age does not preclude an esophagectomy...If only it were that simple.

Orringer MB.

Ann Surg Oncol. 2010 Jun;17(6):1487-9. doi: 10.1245/s10434-010-0989-0. No abstract available.

PMID:
20217251
47.

Richard Anderson: cardiothoracic surgeon personified.

Orringer MB.

Ann Thorac Surg. 2009 Dec;88(6):1729-31. doi: 10.1016/j.athoracsur.2009.09.074.

PMID:
19932224
48.

A histologically defined subset of high-grade dysplasia in Barrett mucosa is predictive of associated carcinoma.

Zhu W, Appelman HD, Greenson JK, Ramsburgh SR, Orringer MB, Chang AC, McKenna BJ.

Am J Clin Pathol. 2009 Jul;132(1):94-100. doi: 10.1309/AJCP78CKIOJWOVFN.

PMID:
19864239
49.

Analysis of cervical esophagogastric anastomotic leaks after transhiatal esophagectomy: risk factors, presentation, and detection.

Cooke DT, Lin GC, Lau CL, Zhang L, Si MS, Lee J, Chang AC, Pickens A, Orringer MB.

Ann Thorac Surg. 2009 Jul;88(1):177-84; discussion 184-5. doi: 10.1016/j.athoracsur.2009.03.035.

PMID:
19559221
50.

Comparative survival in patients with postresection recurrent versus newly diagnosed non-small-cell lung cancer treated with radiotherapy.

Cai XW, Xu LY, Wang L, Hayman JA, Chang AC, Pickens A, Cease KB, Orringer MB, Kong FM.

Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1100-5. doi: 10.1016/j.ijrobp.2009.03.017. Epub 2009 Jun 18.

PMID:
19540063

Supplemental Content

Loading ...
Support Center